Diabetes & Endocrinology

Medicine Matters diabetes is SpringerNature's editorially independent, free to access online resource for healthcare professionals working with diabetes patients. Find the latest news and in-depth articles from medwireNews, read opinions and updates from our clinical advisors, and access a wealth of peer-reviewed research and educational materials.

Visit our dedicated microsite for research news, interviews and in-depth analysis of paediatric endocrinology and growth disorders.

Two phase 2 studies published in The Journal of Clinical Endocrinology & Metabolism in October 2022 suggest that seliciclib, a selective cyclin-dependent kinase inhibitor targeting pituitary adrenocorticotropic 2 hormone production, may improve hypercortisolemia in patients with Cushing’s disease.

The LINC 3 extension study, by Maria Fleseriu and team, suggests that long-term treatment with osilodrostat is associated with sustained benefits for people with Cushing’s disease.